Intel stock price rebounds today: INTC claws back ground after selloff
27 January 2026
1 min read

Intel stock price rebounds today: INTC claws back ground after selloff

New York, January 27, 2026, 10:31 ET — Regular session

Intel shares climbed 3.3% to $43.91 in early trading Tuesday, riding a wider surge in semiconductor stocks. The iShares Semiconductor ETF jumped roughly 2.4%, with Nvidia and AMD also gaining ground.

The decline followed a 5.7% drop for Intel just one day earlier, adding to the fallout from a steep selloff late last week triggered by a weak forecast. Investors remain divided on whether the pressure reflects short-term supply issues or deeper structural problems. 1

This matters now as the stock heads into a jam-packed week: the Federal Reserve kicks off its January policy meeting Tuesday, and risk appetite has been jittery with every earnings update. Chipmakers remain one of the market’s busiest sectors, and Intel’s recent outlook revision leaves almost no margin for error. 2

Intel projected first-quarter revenue between $11.7 billion and $12.7 billion last week. It also forecast a loss of 21 cents per share for the quarter, though its adjusted, or non-GAAP, earnings are expected to break even. Non-GAAP results exclude certain items companies believe obscure core performance. 3

Chief executive Lip-Bu Tan told investors the company is “working aggressively to grow supply to meet strong customer demand,” highlighting the launch of products using Intel’s 18A manufacturing process, its next-gen production technology. 3

The stock’s jump in January set it up for a fall when guidance came in below expectations. TD Cowen analysts called the rally “largely driven by ‘the dream’ rather than the near-term reality or fundamentals.” Intel CFO David Zinsner noted supply issues hit their worst in Q1 but should ease in Q2. 4

On Jan. 23, Intel submitted a prospectus supplement related to a previous deal with the U.S. Department of Commerce, labeled the “selling securityholder.” The company clarified this filing doesn’t guarantee any shares will be sold, nor will Intel get any proceeds from such a sale. 5

Intel flagged the client PC cycle as another near-term priority. It announced that its Core Ultra Series 3 mobile processors will hit online and retail shelves, as well as PC makers’ storefronts, starting Jan. 27. 6

Yet, the risk on the downside remains. Should component bottlenecks and manufacturing yields fail to improve as quickly as Intel anticipates, supply issues might drag on well into the year, capping sales and tightening margins despite steady demand. 7

The Fed’s next move, set for Wednesday, January 28, is the key event on traders’ radar. Meanwhile, Intel investors will be eyeing early signals from the PC rollout as Series 3 systems hit stores this week. 8

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps
Previous Story

Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

Silver price rebounds near $110 after record spike; what traders watch next
Next Story

Silver price rebounds near $110 after record spike; what traders watch next

Go toTop